Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 31, 2016 19:30 ET | Source: Skyline Medical Inc.

Two Skyline Medical Directors along with GLG Pharma’s Chief Operating Officer to be Interviewed on WPSL-AM 1590 MONEYINFO Program

MINNEAPOLIS, Oct. 31, 2016 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain...
October 31, 2016 16:52 ET | Source: The Female Health Company

The Female Health Company Successfully Completes Transformational Merger With Aspen Park Pharmaceuticals Under Modified Terms

--Merger Combines FHC’s Existing FC2 Product with APP’s Deep Drug Development Product Portfolio that Addresses Multi-Billion Dollar Industry Segments-- CHICAGO and NEW YORK, Oct. 31, 2016 (GLOBE...
October 31, 2016 16:30 ET | Source: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Completes $5.2 Million Underwritten Public Offering

NEW YORK, Oct. 31, 2016 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix), today announced the closing of its previously announced underwritten public offering of...
October 31, 2016 15:07 ET | Source: Cellceutix Corporation

Cellceutix Begins Phase 2b Clinical Trial of Oral Prurisol in Moderate-to-Severe Chronic Plaque Psoriasis

BEVERLY, Mass., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Cellceutix Corporation, (OTCQB:CTIX) (“the Company”), a clinical stage biopharmaceutical company developing innovative therapies with dermatology,...
October 31, 2016 14:11 ET | Source: TriCore Reference Laboratories

Lovelace Health System selects TriCore for laboratory management services

ALBUQUERQUE, N.M., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Lovelace Health System announced today that it has selected TriCore Reference Laboratories (TriCore) for inpatient and outpatient laboratory...
October 31, 2016 11:09 ET | Source: Levi & Korsinsky, LLP

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 21, 2016 – SPPI

NEW YORK, Oct. 31, 2016 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of...
October 31, 2016 10:42 ET | Source: Capital Orletto inc.

Orletto annonce l'obtention du visa pour son prospectus définitif

QUÉBEC, QUÉBEC--(Marketwired - 31 oct. 2016) - NE PAS DISTRIBUER AUX AGENCES DE PRESSE AMÉRICAINES NI DIFFUSER AUX ÉTATS-UNIS Benoit Chotard,...
October 31, 2016 10:42 ET | Source: Orletto Capital Inc.

Orletto Announces Receipt for Final Prospectus

QUÉBEC CITY, QUÉBEC--(Marketwired - Oct. 31, 2016) - NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Benoit...
October 31, 2016 10:03 ET | Source: MailMyPrescriptions.com

MailMyPrescriptions.com Earns Coveted LegitScript Certification

BOCA RATON, Fla., Oct. 31, 2016 (GLOBE NEWSWIRE) -- MailMyPrescriptions.com announced today that it had crossed a major milestone, earning certification from LegitScript. LegitScript's pharmacy...
October 31, 2016 09:45 ET | Source: Cellectar Biosciences, Inc.

Cellectar Biosciences Announces Design for NCI-Supported Phase II Study of CLR 131 in Multiple Myeloma and Other Hematologic Malignancies

MADISON, Wis., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused, clinical stage biotechnology company, today announces the study...
October 31, 2016 09:33 ET | Source: American College of Prosthodontists

Dr. Edmond Bedrossian Named Honorary Member of the American College of Prosthodontists

CHICAGO, Oct. 31, 2016 (GLOBE NEWSWIRE) -- Edmond Bedrossian, DDS, has been named an Honorary Member of the American College of Prosthodontists (ACP). He was recognized during the 46th Annual Session...
October 31, 2016 09:30 ET | Source: Nexstim Oyj

Skuldebrevslånet mellan Nexstim Abp och Bracknor konverteras till aktier

Pressmeddelande, Helsingfors den 31 oktober 2016 kl. 15.30 Nexstim Abp (NXTMH:HEX, NXTMS:STO) ("Nexstim" eller "bolaget"), som är ett medicintekniskt företag med ett banbrytande system som...
October 31, 2016 09:30 ET | Source: Nexstim Oyj

The conversion of the convertible loan between Nexstim Plc and Bracknor

Company announcement, Helsinki, 31 October 2016 at 3.30 pm Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or the "Company"), a medical technology company with a pioneering navigated non-invasive...
October 31, 2016 09:00 ET | Source: Health Advance Inc.

Health Advance Inc. Signs Letter of Intent to acquire Product Formulations

LAS VEGAS, NV--(Marketwired - Oct 31, 2016) - Health Advance Inc. (the "Company") (OTC PINK: HADV) is pleased to announce it has entered into a non-binding Letter of Intent to acquire certain...
October 31, 2016 09:00 ET | Source: Patient Home Monitoring Corp.

Patient Home Monitoring Announces Appointment of New Chief Financial Officer

LAFAYETTE, LOUISIANA--(Marketwired - Oct. 31, 2016) - NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF...
October 31, 2016 09:00 ET | Source: Celsion Corporation

Celsion Presents Data on ThermoDox® plus Optimized RFA in Intermediate Primary Liver Cancer at the 3rd Asian Conference on Tumor Ablation (ACTA)

LAWRENCEVILLE, N.J., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), an oncology drug development company, today announced the presentation of data from the Company’s HEAT...
October 31, 2016 09:00 ET | Source: Rexahn Pharmaceuticals

Rexahn Pharmaceuticals Receives a Notice of Allowance from the U.S. Patent and Trademark Office for a Patent Covering the Manufacturing of RX-3117 – A Cancer Cell Specific Anticancer Agent

ROCKVILLE, Md., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of...
October 31, 2016 09:00 ET | Source: Antares Pharma Inc

Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer

EWING, N.J., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced the appointment of Fred M. Powell to the position of Senior Vice President, Chief Financial...
October 31, 2016 08:50 ET | Source: Chembio Diagnostics, Inc.

Chembio to Host Conference Call to Discuss Third Quarter 2016 Financial Results

MEDFORD, N.Y., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ:CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, announced today that...
October 31, 2016 08:30 ET | Source: Mateon Therapeutics

Mateon Announces Presentation of CA4P Posters at Meeting of the International Gynecologic Cancer Society

- Patients with Measurable Disease Showed Significantly Improved Progression-Free Survival - - Progression-Free Survival Improved by 6.2 Months for Patients with Larger Tumors - SOUTH SAN...
October 31, 2016 08:30 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Announces Identification of High Responder Patient Subgroup from Ampligen® Phase III Trial in Patients with CFS/ME

51% of patients in the high responder subset receiving Ampligen vs. 18% of placebo patients demonstrated improvement of at least 25% in exercise tolerance Data presented at the 12th...
October 31, 2016 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Receives Special Protocol Assessment (SPA) from the FDA for Second Phase 3 Clinical Trial Evaluating Firdapse for the Treatment of LEMS

CORAL GABLES, Fla., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative...
October 31, 2016 08:00 ET | Source: Easton Pharmaceuticals Inc.

Easton Pharmaceuticals and Partner BMV Medica Announce Closing Of First Distribution Agreement For Three Exclusively Licensed Women's Health Products: VagiSense, AmnioSense and Gynofit With Windsor Pharmaceuticals For Central America and The Caribbean

TORONTO, ON--(Marketwired - Oct 31, 2016) - Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces it has closed its first Sales & Distribution agreement with Windsor Pharmaceuticals SA for...
October 31, 2016 08:00 ET | Source: Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies Presents the ITI-007 Clinical Development Program in Schizophrenia at the CNS Summit 2016 Annual Conference

NEW YORK, Oct. 31, 2016 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) today announced presentation (in oral and poster forms) of results from its clinical development program in...
October 31, 2016 08:00 ET | Source: TESARO, Inc.

TESARO Announces Presentation of Niraparib Data at the 2016 IGCS Biennial Meeting

WALTHAM, Mass., Oct. 31, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the presentation of data from the ENGOT-OV16/NOVA trial...
October 31, 2016 08:00 ET | Source: Aclaris Therapeutics, Inc.

Aclaris Therapeutics Submits Investigational New Drug Application for ATI-50001 to Treat Alopecia Universalis and Alopecia Totalis

MALVERN, Pa., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), today announced that it has submitted an Investigational New Drug Application (IND) to the U.S. Food and...
October 31, 2016 08:00 ET | Source: MyoKardia, Inc.

MyoKardia to Present at Two Upcoming Investor Conferences in November

SOUTH SAN FRANCISCO, Calif., Oct. 31, 2016 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical stage biopharmaceutical company pioneering a precision medicine approach for the...
October 31, 2016 07:30 ET | Source: KaloBios Pharmaceuticals Inc.

KaloBios CEO to Present at the Priority Review Voucher Summit

BRISBANE, Calif., Oct. 31, 2016 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
October 31, 2016 07:30 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences Begins Enrollment of Second Cohort of Phase 2 Trial of CLBS03 as a Treatment for Type 1 Diabetes Following Favorable Safety Data from First Cohort

Earlier assessment of clinical safety permits acceleration of trial timelineSanford Research to Provide Operational Support at its Clinical Sites for Remainder of TrialBASKING RIDGE, N.J., Oct. 31,...
October 31, 2016 07:30 ET | Source: Spark Therapeutics, Inc.

Spark Therapeutics to Participate in Multiple Upcoming Conferences

PHILADELPHIA, Oct. 31, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company seeking to transform the lives of patients with debilitating genetic...
October 31, 2016 07:00 ET | Source: Abiomed

Abiomed Launches Impella Quality (IQ) Assurance Program and Shares Insight From Largest Database of Real-World Evidence of High-Risk PCI and Cardiogenic Shock Patients

DANVERS, Mass., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today its Impella Quality (IQ)...
October 31, 2016 07:00 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma to Present at the BIO-Europe 2016 Conference

TEL-AVIV, Israel, Oct. 31, 2016 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and...
October 31, 2016 07:00 ET | Source: pSivida Corp

pSivida Corp. Announces First Quarter Fiscal Year 2017 Financial Results Release Date and Conference Call Information

WATERTOWN, Mass., Oct. 31, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products primarily for treating eye...
October 31, 2016 07:00 ET | Source: Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc. Reports Fiscal Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update

SANTA MONICA, Calif., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for...
October 31, 2016 03:30 ET | Source: GENFIT S.A.

GENFIT COMPLETES HIGHLY SUCCESSFUL RIGHTS OFFERING OF APPROX. €44.6 MILLION

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Not for publication, release or...
October 31, 2016 03:30 ET | Source: GENFIT S.A.

GENFIT : TRES LARGE SUCCES DE L'AUGMENTATION DE CAPITAL AVEC MAINTIEN DU DROIT PREFERENTIEL DE SOUSCRIPTION DES ACTIONNAIRES DE GENFIT D'ENVIRON 44,6 MILLIONS EUROS

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Ne pas distribuer, diffuser, directement...
October 31, 2016 03:00 ET | Source: Revenio Group Corporation

Revenio Group Corporation: Interim Report January 1 - September 30, 2016

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Revenio Group...
October 31, 2016 03:00 ET | Source: Scibase Holding AB

Följande personer har utsetts att ingå i SciBase Holdings valberedning inför årsstämman 2017:

David Sonnek (representerande SEB Venture Capital och SEB pensionsstiftelse), Per Nordberg (Fouriertransform), Renee Aguiar-Lucander (Omega fund IV L.P.), Tord Lendau (Styrelsens...
October 31, 2016 03:00 ET | Source: Scibase Holding AB

The following people have been appointed as members of SciBase Holding’s election committee for the Annual General Meeting in 2017:

David Sonnek (representing SEB Venture Capital and SEB pensionsstiftelse), Per Nordberg (Fouriertransform), Renee Aguiar-Lucander (Omega fund IV L.P.), Tord Lendau (Chairman of the Board). The...
October 31, 2016 02:15 ET | Source: Novartis Pharma AG

Novartis Wins Two Prestigious Prix Galien Foundation Awards; Gleevec® recognized as "Discovery of the Decade" for Best Pharmaceutical Product, Cosentyx® as Best Biotechnology Product

Basel, October 31, 2016 - Novartis has been awarded the prestigious 2016 Prix Galien USA Award for Best Biotechnology Product for Cosentyx® (secukinumab), as well as the Prix Galien Foundation...
October 31, 2016 02:00 ET | Source: Vistin Pharma ASA

Vistin Pharma ASA third quarter 2016: Investing in future growth

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, Norway, 31 October 2016 Norwegian...
October 30, 2016 19:00 ET | Source: MediciNova, Inc.

MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the 27th International Symposium on ALS/MND in Dublin, Ireland

LA JOLLA, Calif., Oct. 30, 2016 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock...
October 28, 2016 16:15 ET | Source: Amedica Corp

Amedica Corporation to Release Third Quarter 2016 Financial Results and Host Conference Call

SALT LAKE CITY, UT--(Marketwired - Oct 28, 2016) - Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today...
October 28, 2016 14:34 ET | Source: Sanofi Winthrop Industrie

Sanofi : Sanofi et Regeneron reçoivent une lettre de réponse complète de la FDA au sujet du sarilumab, leur traitement expérimental de la polyarthrite rhumatoïde

Sanofi et Regeneron reçoivent une lettre de réponse complète de la FDA au sujet du sarilumab, leur traitement expérimental de la polyarthrite rhumatoïde Paris et Tarrytown (New York) - Le 28...
October 28, 2016 14:34 ET | Source: Sanofi Winthrop Industrie

Sanofi : Sanofi and Regeneron Receive Complete Response Letter from FDA for Sarilumab, an Investigational Treatment for Rheumatoid Arthritis

Sanofi and Regeneron Receive Complete Response Letter from FDA for Sarilumab, an Investigational Treatment for Rheumatoid Arthritis Paris and Tarrytown, N.Y. - October 28, 2016 - Sanofi and...
October 28, 2016 10:58 ET | Source: Mondelez International, Inc.

Mondelēz Global LLC lleva a cabo retiro voluntario a nivel nacional del producto Oreo Fudge Cremes vendido en Estados Unidos

EAST HANOVER, N.J., Oct. 28, 2016 (GLOBE NEWSWIRE) -- Mondelēz Global LLC anunció hoy el retiro voluntario a nivel nacional en Estados Unidos, incluyendo los territorios estadounidenses de Puerto...
October 28, 2016 10:58 ET | Source: Mondelez International, Inc.

Mondelēz Global LLC Conducts Nationwide Voluntary Recall of Oreo Fudge Cremes Product Sold in the U.S.

EAST HANOVER, N.J., Oct. 28, 2016 (GLOBE NEWSWIRE) -- Mondelēz Global LLC announced today a nationwide voluntary recall in the United States, including the U.S. Territories of Puerto Rico, St....
October 28, 2016 10:04 ET | Source: Theratechnologies inc.

Des résultats concernant l'ibalizumab, un produit biologique à action prolongée sous étude clinique, seront présentés lors d'une présentation orale de dernière minute à IDWeek 2016(MC)

MONTRÉAL, CANADA--(Marketwired - 28 oct. 2016) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) a annoncé de nouveaux résultats concernant le paramètre primaire...
October 28, 2016 10:01 ET | Source: Theratechnologies Inc.

Theratechnologies: Results of HIV Biologic and Long-Acting Investigational Antiretroviral Ibalizumab to be Presented in Late-Breaker Session at IDWeek 2016(TM)

MONTREAL, CANADA--(Marketwired - Oct. 28, 2016) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) announced additional results related to the primary endpoint of the ibalizumab Phase...
October 28, 2016 09:05 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics Appoints Biopharmaceutical Veteran Willard Dere, M.D. to Board of Directors

PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Oct. 28, 2016 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), today announced that Willard Dere, M.D., Professor of Internal Medicine...